Skip to content

Clinical trials

Completed Diabetes Mellitus trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Status: Completed Country / region: South Korea Clear all

164 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20044
20051
20069
200711
20089
200918
201016
201117
20123
201315
201410
20158
20165
201711
20185
20193
20205
20224
20233
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed164

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S33
Seoul National University Bundang Hospital16
AstraZeneca13
Seoul National University Hospital13
Eli Lilly and Company9
Hanmi Pharmaceutical Company Limited6
Yonsei University6
Samsung Medical Center5
Jeil Pharmaceutical Co., Ltd.4
The Catholic University of Korea4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus164
Diabetes Mellitus, Type 274
Diabetes Mellitus, Type 19
Hypertension9
Insulin Resistance9
Coronary Artery Disease7
Hyperlipidemias6
Metabolic Diseases6
Glucose Metabolism Disorders5
Prediabetic State5

Trials

Showing 1 to 25 of 164. Each trial links to its page on Pharma Observatory.

64 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.